Ole Peter Kristiansen

Author

Also Known As

O P Kristiansen, O. P. Kristiansen, O.P Kristiansen, Olav Wendelboe Nielsen, Ole Kristiansen, Ole P Kristiansen, Ole P. Kristiansen, Ole Peter Kristiansen

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

Steno Diabetes Centers Copenhagen University Hospital Amager Hospital Bispebjerg Hospital University of Copenhagen

About

Ole Peter Kristiansen is an author at Steno Diabetes Centers specializing in medicine, genetics, and diabetes.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	2.3K
2	Public Health	6	6	381
3	Health Sciences	1	1	20
4	Biochemistry	1	1	20
5	Biostatistics	1	1	24

Ole Peter Kristiansen

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed, The Lancet Diabetes ManagementCardiovascular DiseaseDiabetesClinical TrialsType 2	2018	1.7K
Early Versus Standard Care Invasive Examination and Treatment of Patients With Non-ST-Segment Elevation Acute Coronary Syndrome Klaus F. Kofoed, Henning Kelbæk, Peter Riis Hansen, Circulation	2018	261
Coronary CT Angiography in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome Jesper J. Linde, Henning Kelbæk, Thomas Fritz Hansen, Journal of the American College of Cardiology Percutaneous Coronary InterventionCoronary Ct AngiographyCardiovascular DiseaseMyocardial InfarctionCoronary Artery Disease	2020	190
Echocardiographic Abnormalities and Predictors of Mortality in Hospitalized COVID-19 Patients: The ECHOVID-19 Study Mats Christian Højbjerg Lassen, Kristoffer Grundtvig Skaarup, Jannie Nørgaard Lind, ESC Heart Failure	2020	110
Effects of Liraglutide on Heart Rate and Heart Rate Variability: A Randomized, Double-Blind, Placebo-Controlled Crossover Study Preman Kumarathurai, Christian Anholm, Bjørn Strøier Larsen, Diabetes Care	2016	89
Liraglutide in combination with metformin may improve the atherogenic lipid profile and decrease C-reactive protein level in statin treated obese patients with coronary artery disease and newly diagnosed type 2 diabetes: A randomized trial Christian Anholm, Preman Kumarathurai, Lene Rørholm Pedersen, Atherosclerosis ObesityMetabolic SyndromeC-reactive Protein LevelCardiovascular DiseaseMedicine	2019	70
Recovery of cardiac function following <scp>COVID</scp> ‐19 – <scp>ECHOVID</scp> ‐19: a prospective longitudinal cohort study Mats Christian Højbjerg Lassen, Kristoffer Grundtvig Skaarup, Jannie Nørgaard Lind, European Journal of Heart Failure	2021	61
IDDM12 ( <i>CTLA4</i> ) on 2q33 and <i>IDDM13</i> on 2q34 in Genetic Susceptibility to Type 1 Diabetes (Insulin-dependent) Z. M. Larsen, Ole Peter Kristiansen, Eugènia Mato, Autoimmunity	1999	57
Effects of the glucagon-like peptide-1 receptor agonist liraglutide on systolic function in patients with coronary artery disease and type 2 diabetes: a randomized double-blind placebo-controlled crossover study Preman Kumarathurai, Christian Anholm, Olav Wendelboe Nielsen, Cardiovascular Diabetology	2016	54
Intensity versus duration of physical activity: implications for the metabolic syndrome. A prospective cohort study Adam Hoegsbro Laursen, Ole Peter Kristiansen, Jacob Louis Marott, BMJ Open	2012	52

Page 1